Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0150364002
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02533472 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02533472 | SAMSUNG BIOEPIS CO., LTD | HADLIMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02533480 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02533480 | SAMSUNG BIOEPIS CO., LTD | HADLIMA PUSHTOUCH | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458349 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458349 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458357 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02458357 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Approved | 02466872 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02466872 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474220 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474220 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Approved | 02474255 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 10 MG / 0.1 ML |
Approved | 02474255 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 10 MG / 0.1 ML |
Marketed | 02474263 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Marketed | 02474263 | ABBVIE CORPORATION | HUMIRA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Marketed | 02542315 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Marketed | 02542315 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 20 MG / 0.2 ML |
Marketed | 02542323 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02542323 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02542331 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02542331 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02542358 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02542358 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02542366 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02542366 | SANDOZ CANADA INCORPORATED | HYRIMOZ | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02523949 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523949 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523957 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523957 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523965 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02523965 | JAMP PHARMA CORPORATION | SIMLANDI | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02523760 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523760 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523779 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02523779 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 40 MG / 0.4 ML |
Marketed | 02535076 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535076 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535084 | CELLTRION INC. | YUFLYMA | Human | Yes | Prescription | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Marketed | 02535084 | CELLTRION INC. | YUFLYMA | Human | Yes | Schedule D | 1 | ADALIMUMAB | 80 MG / 0.8 ML |
Application information
Related information
Contact us
Version 4.0.3